- Disease: Post-COVID-19
- Study type: Randomised Clinical Trial
- Study type descriptors: Interventional, Single centre
- Study aim: To assess the safety and efficacy of plitidepsin as a potential treatment for long COVID
- Number of participants enrolled: Enrollment ongoing
- Study enrolling from to
- Study includes follow-up for 3 months
Study Data
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Plitidepsin
- Antineoplastic agent
External Links
Other information
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to